Answers are grounded in this paper and cite their sources.
Affibody-mediated PNA-based pretargeting shows promise for HER2-expressing tumor radiotherapy. In our recent study, a 15-mer Z
No takes yet. Share an insight, caveat, or question.
Westerlund et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: